ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

71
Analysis
Health CareIndia
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
28 Oct 2020 13:51

Sensex Index Rebalance Preview: Take Profit on Strong Outperformance

With the review period for the Sensex almost complete, we still see DRRD as a high probability inclusion and ONGC as a deletion. With DRRD...

Logo
340 Views
Share
21 Oct 2020 03:04

India:  Confidence Returns Among EM Active Managers

Global EM managers strengthen India exposure during the recent market turbulence.  Ownership increases across Energy and Consumer Discretionary,...

Logo
246 Views
Share
06 Sep 2020 14:25

Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two

The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...

Logo
682 Views
Share
21 Aug 2020 05:59

NIFTY50 Index Rebalance - SBI Life Could Outperform on Index Inclusion

Last evening, the Index Maintenance Sub-Committee (IMSC) of NSE Indices announced the results of the September index review for the NIFTY Index...

Logo
451 Views
Share
29 Jul 2020 07:19

NIFTY50 Index Rebalance - HDFC Life at All Time High On Inclusion, Time to Switch

On 2 July, the Index Maintenance Sub-Committee (IMSC) of NSE Indices Limited made an ad-hoc change to the NIFTY Index (NIFTY...

Logo
501 Views
Share
x